SCENESSE
Active substance: afamelanotide
IMPLANT · AFAMELANOTIDE 16 mg/16mg
United StatesActive
Marketing holder: CLINUVEL INC.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- AFAMELANOTIDE · 16 mg/16mg
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12090-f069-7bde-874a-a0f4f8b28134;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73372-0116
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 73372-0116 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73372-0116 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73372-0116 · Verified 2026-10-09 · open in source